Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
A. Torres de Pinedo et al. / Tetrahedron 61 (2005) 7654–7660
7657
or 1:1 depending on the polarity of final compound) to yield
the phenolic fatty acid ester. In the case of the reactions with
butyrate ethyl ester, no final chromatography was needed.
All compounds were O95% pure as observed by H NMR
spectroscopy.
1.25 (m, 24H, –CH2–), 0.87 (t, JZ6.3 Hz, 3H, –CH3); 13C
NMR (75 MHz, CDCl3): d 174.2 (–COO–), 134.0 (Ph-
CH]CH–), 121.3 (Ph-CH]CH–), 143.9, 143.8, 129.9,
120.2, 115.5, 113.3 (Ar), 65.2 (–CH2OCO–), 34.4, 32.0,
30.4, 29.8, 29.7, 29.5, 29.4, 29.3, 29.2, 25.1, 22.8 (–CH2–),
14.2 (–CH3); HRMS FABC calcd 427.2824 for
C25H40O4Na [MCNa]C, found 427.2819.
1
3.2. HPLC procedure
Monitoring by HPLC was carried out using 2695 Alliance
Waters separation system and a 2996 photodiode array
detector. The column was a Symmetry C18, 250!4.0 mm,
5 mm particle size, protected with a C18 precolumn. The
mobile phase A was acetonitrile and B was 1% acetic acid in
water. Gradient started on 92% A for 4 min, then linear
ramp to 100% A in 6 more min, maintaining 100% A for
8 min, and returning to starting conditions in 2 min. Flow
rate was 1 mL/min and detection was achieved at 280 nM.
3.2.5. 3,4-Dihydroxybenzylic butyrate 9. 75%. Trans-
parent syrup; 1H NMR (300 MHz, CDCl3): d 6.88 (d,
JZ1.8 Hz, 1H, ar), 6.83 (d, JZ8.0 Hz, 1H, ar), 6.79 (dd,
JZ8.0, 1.7 Hz, 1H, aro), 4.99 (s, 2H, PhCH2OOC–), 2.31 (t,
JZ7.4 Hz, 2H, –OOC–CH2–), 1.65 (h, JZ7.4 Hz, 2H,
OOC–CH2–CH2), 0.92 (t, JZ7.4 Hz, 3H, –CH3); 13C NMR
(75 MHz, CDCl3): d 174.5 (–COO–), 144.0, 143.7, 128.9,
121.5, 115.9, 115.4 (Ar), 66.3 (PhCH2OCO–), 36.4 (–OOC–
CH2–), 18.5 (–OOC–CH2–CH2), 13.7 (–CH3); HRMS
FABC calcd 222.0892 for C12H14O4Na [MCNa]C,
found 222.0892.
3.2.1. 3,4-Dihydroxybenzylic palmitate 5. 98%. White
1
solid; H NMR (300 MHz, CDCl3): d 6.89 (d, JZ1.5 Hz,
1H, ar), 6.84 (d, JZ8.1 Hz, 1H, ar), 6.79 (dd, JZ8.0,
1.7 Hz, 1H, ar), 4.99 (s, 2H, PhCH2OOC–), 2.32 (t,
JZ7.4 Hz, 2H, –OOC–CH2–), 1.61 (q, JZ6.0 Hz, 2H,
OOC–CH2–CH2), 1.25 (m, 24H, –CH2–), 0.87 (t, JZ
6.4 Hz, 3H, –CH3); 13C NMR (75 MHz, CDCl3): d 175.7
(–COO–), 145.2, 144.9, 130.3, 122.9, 117.2, 116.7 (Ar),
67.5 (PhCH2OCO–), 35.9 (–OOC–CH2–), 33.3, 31.1, 31.0,
30.8, 30.7, 30.6, 30.5, 26.3, 24.1 (–CH2–), 15.5 (–CH3);
HRMS FABC calcd 401.2668 for C23H38O4Na [MCNa]C,
found 401.2672.
3.2.6. 2-(3,4-Dihydroxyphenyl) ethyl butyrate 10. 59%.
Transparent syrup; 1H NMR (300 MHz, CDCl3): d 6.78 (d,
JZ8.1 Hz, 1H, ar), 6.73 (d, JZ1.5 Hz, 1H, ar), 6.63 (dd,
JZ8.0, 1.5 Hz, 1H, ar), 6.19 (1s (w), 1H, Ph-OH), 6.0 (1s
(w), 1H, Ph-OH), 4.23 (t, JZ7.1 Hz, 2H, –CH2OOC–), 2.79
(t, JZ7.1 Hz, 2H, Ph-CH2–), 2.27 (t, JZ7.5 Hz, 2H,
–OOC–CH2–), 1.65 (h, JZ7.4 Hz, 2H, –OOC–CH2–CH2),
0.92 (t, JZ7.4 Hz, 3H, –CH3); 13C NMR (75 MHz, CDCl3):
d 174.9 (–COO–), 143.9, 142.6, 130.5, 121.3, 115.9, 115.5
(Ar), 65.3 (–CH2OCO–), 36.4 (–OOC–CH2–), 34.5 (Ph-
CH2–), 18.5 (–OOC–CH2–CH2), 13.7 (–CH3); HRMS
FABC calcd 247.0946 for C12H16O4Na [MCNa]C,
found 247.0947.
3.2.2. 2-(3,4-Dihydroxyphenyl) ethyl palmitate 6. 98%.
White solid; 1H NMR (300 MHz, CDCl3): d 6.78 (d,
JZ8.1 Hz, 1H, ar), 6.73 (d, JZ1.5 Hz, 1H, ar), 6.63 (dd,
JZ8.0, 1.5 Hz, 1H, ar), 4.23 (t, JZ7.1 Hz, 2H, –CH2OOC–),
2.80 (t, JZ7.1 Hz, 2H, ar-CH2–), 2.28 (t, JZ7.5 Hz, 2H,
–OOC–CH2–), 1.58 (q, JZ6.1 Hz, 2H, –OOC–CH2–CH2),
1.25 (m, 24H, –CH2–), 0.87 (t, JZ6.4 Hz, 3H, –CH3); 13C
NMR (75 MHz, CDCl3): d 174.5 (–COO–), 143.7, 142.4,
130.7, 121.4, 116.0, 115.5 (Ar), 65.1 (–CH2OCO–), 34.6,
34.5, 32.0, 29.8, 29.7, 29.7, 29.5, 29.4, 29.3, 29.2, 25.0,
24.8, 22.8 (–CH2–), 14.2 (–CH3); HRMS FABC calcd
415.2824 for C24H40O4Na [MCNa]C, found 415.2819.
3.2.7. 3-(3,4-Dihydroxyphenyl) propyl butyrate 11. 97%.
Transparent syrup; 1H NMR (300 MHz, CDCl3): d 6.77 (d,
JZ8.0 Hz, 1H, ar), 6.68 (d, JZ1.5 Hz, 1H, ar), 6.58 (dd,
JZ8.0, 1.6 Hz, 1H, ar), 4.07 (t, JZ6.6 Hz, 2H, –CH2OOC–),
2.55 (t, JZ7.4 Hz, 2H, ar-CH2–), 2.30 (t, JZ7.5 Hz, 2H,
–OOC–CH2–), 1.89 (q, JZ6.7 Hz, 2H, –CH2–), 1.65 (h, JZ
7.5 Hz, 2H, –OOC–CH2–CH2), 0.95 (t, JZ7.4 Hz, 3H,
–CH3); 13C NMR (75 MHz, CDCl3): d 174.6 (–COO–),
143.8, 141.9, 134.2, 120.8, 115.6, 115.4 (Ar), 63.9
(–CH2OCO–), 36.4 (–OOC–CH2–), 31.5, 30.3, 18.6
(–CH2–), 13.7 (–CH3); HRMS FABC calcd 261.1103 for
C13H18O4Na [MCNa]C, found 261.1107.
3.2.3. 3-(3,4-Dihydroxyphenyl) propyl palmitate 7. 97%.
White solid; 1H NMR (300 MHz, CDCl3): d 6.76 (d,
JZ8.0 Hz, 1H, ar), 6.68 (d, JZ1.8 Hz, 1H, ar), 6.58 (dd,
JZ8.0, 1.8 Hz, 1H, ar), 4.06 (t, JZ6.6 Hz, 2H, –CH2OOC–),
2.55 (t, JZ7.4 Hz, 2H, ar-CH2–), 2.30 (t, JZ7.5 Hz, 2H,
–OOC–CH2–), 1.88 (q, JZ6.7 Hz, 2H, –CH2–), 1.65 (q, JZ
7.2 Hz, 2H, –OOC–CH2–CH2), 1.24; 13C NMR (75 MHz,
CDCl3): d 174.5 (–COO–), 143.7, 141.8, 134.3, 120.8,
115.6, 115.5 (Ar), 63.8 (–CH2OCO–), 34.5, 32.0, 31.5, 30.4,
29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 25.1, 22.8 (–CH2–),
14.2 (–CH3); HRMS FABC calcd 429.2981 for
C25H42O4Na [MCNa]C, found 429.2977.
3.2.8. 3,4-Dihydroxycinnamyl butyrate 12. 96%. Trans-
parent syrup; H NMR (300 MHz, CDCl3): d 6.92 (s, 1H,
1
ar), 6.80 (s, 2H, ar), 6.51 (d, JZ15.8 Hz, 1H, Ph-CH]CH–
CH2–), 6.09 (dt, JZ15.8, 6.6 Hz, 1H, Ph-CH]CH–CH2–),
4.69 (d, JZ6.5 Hz, Ph-CH]CH–CH2–), 2.32 (t, JZ7.4 Hz,
2H, –OOC–CH2–), 1.66 (h, JZ7.4 Hz, 2H, –OOC–CH2–
CH2), 0.95 (t, JZ7.4 Hz, 3H, –CH3); 13C NMR (75 MHz,
CDCl3): d 174.1 (–COO–), 134.1 (Ph-CH]CH–), 121.4
(Ph-CH]CH–), 144.0, 143.8, 129.8, 120.2, 115.5, 113.3
(Ar), 65.3 (–CH2OCO–), 36.4 (–OOC–CH2–), 18.6 (–CH2–),
13.7 (–CH3); HRMS FABC calcd 259.1105 for
C13H16O4Na [MCNa]C, found 259.1109.
3.2.4. 3,4-Dihydroxycinnamyl palmitate 8. 71%. White
solid; 1H NMR (300 MHz, CDCl3): d 6.92 (s, 1H, ar), 6.81
(s, 2H, ar), 6.51 (d, JZ15.8 Hz, 1H, Ph-CH]CH–CH2–),
6.09 (dt, JZ15.8, 6.6 Hz, 1H, Ph-CH]CH–CH2–), 4.69 (d,
JZ6.5 Hz, Ph-CH]CH–CH2–), 2.33 (t, JZ7.4 Hz, 2H,
–OOC–CH2–), 1.63 (q, JZ7.0 Hz, 2H, –OOC–CH2–CH2),
3.2.9. 3,4-Dihydroxybenzylic stearate 13. 74%. White
1
solid; H NMR (300 MHz, CDCl3): d 6.88 (d, JZ1.8 Hz,
1H, ar), 6.83 (d, JZ8.1 Hz, 1H, ar), 6.78 (dd, JZ8.0,